Cipla | CIPLA - Bénéfice Avant Impôts

Prix De L'Action
1,199.70
Variation Quotidienne
-24.50 -2.00%
Mensuellement
-11.24%
Annuel
-17.40%
Q2 Prévisions
1,216.46




Bénéfice Avant Impôts Changement Date
Arca Biopharma USD -29.58M 694K 2025-12
aTyr Pharma USD -25.75M 6.22M 2025-09
Bio Path USD -976K 3.62M 2025-09
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cara Therapeutics USD -4.91M 3.17M 2025-03
Cipla INR 11.69B 6.85B 2025-12
Dr.Reddys Laboratories INR 15.68B 2.38B 2025-12
Esperion Therapeutics USD 63.67M 95M 2025-12
Immunic USD -21.38M 8.2M 2024-06
Minerva Neurosciences USD 22.51M 30.74M 2024-09
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sun Pharmaceuticals INR 41.68B 9.95B 2025-09
TherapeuticsMD USD -1.05M 241K 2024-06
UPL INR 7.27B 850M 2025-12